Search

everythinglearnresearchcommunity

for

Search:↓

People with androgenic alopecia are more likely to have metabolic syndrome than healthy individuals.

A patient with HAIR-AN syndrome, PCOS, and Hashimoto's thyroiditis improved with early diagnosis and treatment to prevent serious health problems.

Metformin is safe in early pregnancy for women with PCOS and may reduce certain risks.

The document concludes that insulin resistance is key in PCOS development and early treatment is crucial to prevent complications.

Women with PCOS have a higher risk of metabolic syndrome and need lifestyle changes and treatment.

Combining antidiabetic drugs, hormonal therapies, and lifestyle changes can improve health in women with PCOS.

Myo-inositol supplements may improve insulin sensitivity and help with conditions like PCOS and gestational diabetes, but more research is needed.

Metformin and rosiglitazone improve blood vessel function in women with PCOS, with metformin also reducing insulin resistance and testosterone levels.

Insulin resistance might not be enough to worsen blood vessel function in young, nonobese women with polycystic ovary syndrome.

Tirzepatide may improve hair loss by reducing insulin resistance.

Women with PCOS have altered brain structure and reduced cognitive performance.

Hormonal therapies are effective for managing hair and skin symptoms in women with PCOS.

Oxidative stress is a key factor in the development of Polycystic Ovary Syndrome, and weight management can improve symptoms.

PCOS is caused by both genetics and environmental factors like diet and obesity.

Metformin helps manage polycystic ovary syndrome by improving insulin resistance and ovulation, but more research is needed on its full effects.

Metformin is effective for treating excessive hair growth in women with PCOS and may work better than the standard treatment in some ways.

Polycystic Ovary Syndrome likely starts in childhood and may be genetic and influenced by early hormone exposure.

Women with PCOS have more body fat and thicker fat layers in certain abdominal areas than women without PCOS.

The conclusion is that the best initial treatment for hirsutism is usually oral contraceptives, with the addition of antiandrogens or insulin sensitizers if needed, and topical eflornithine or laser treatments as supplementary options.

Cognitive behavioral strategies help women with PCOS make lifestyle changes to improve their health.

High levels of TNF-α may contribute to obesity and insulin resistance in PCOS, but not due to the C850T genetic variation.

Chromium supplements don't improve insulin, hormone levels, or cholesterol in women with PCOS but raise testosterone levels.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Polycystic ovary syndrome is a common hormonal disorder in women, linked to increased risk of metabolic and heart diseases, and needs more research for better understanding and treatment.

Obesity changes androgen levels in women with PCOS, leading to higher testosterone relative to androstenedione.

Obese Hispanic women with PCOS are at higher risk for metabolic problems than non-Hispanic white women.

The document says PCOS is a common hormonal disorder in women, diagnosed by certain criteria, and managed with lifestyle changes and various medications.

Different types of PCOS in Chinese Han women show varying levels of male hormone and metabolic issues.

Mild thyroid issues don't affect the metabolism and hormones of women with PCOS.

A certain genetic variation is linked to a higher risk of polycystic ovarian syndrome.